Protective mechanism of GLP-1 on kidney in diabetic kidney disease patients

Ke LI,Jiaqing SHAO

DOI: https://doi.org/10.3969/j.issn.1006-6187.2017.10.022

2017-01-01

Abstract:Diabetic kidney disease is a common complication in patients with diabetes mellitus and so far,lacking effective therapy aiming at it.Glucagon like peptide-1 (GLP-1) receptor agonist is a novel hypoglycemic agent associated with incretin.Studies have shown that GLP-1 have additional renal protection independent of its hypoglycemic effect,mainly through the mechanisms such as antihypertension,reducing glomerular hyperfiltration,lowering proteinuria,anti-inflammatory,antioxidative stress and anti-RASS.In this review,we will summary their renal effects and mechanisms from the basic and clinical evidences.